日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Retraction Note: Antibodies against endogenous retroviruses promote lung cancer immunotherapy

撤稿声明:针对内源性逆转录病毒的抗体可促进肺癌免疫疗法

Ng, Kevin W; Boumelha, Jesse; Enfield, Katey S S; Almagro, Jorge; Cha, Hongui; Pich, Oriol; Karasaki, Takahiro; Moore, David A; Salgado, Roberto; Sivakumar, Monica; Young, George; Molina-Arcas, Miriam; de Carné Trécesson, Sophie; Anastasiou, Panayiotis; Fendler, Annika; Au, Lewis; Shepherd, Scott T C; Martínez-Ruiz, Carlos; Puttick, Clare; Black, James R M; Watkins, Thomas B K; Kim, Hyemin; Shim, Seohee; Faulkner, Nikhil; Attig, Jan; Veeriah, Selvaraju; Magno, Neil; Ward, Sophia; Frankell, Alexander M; Al Bakir, Maise; Lim, Emilia L; Hill, Mark S; Wilson, Gareth A; Cook, Daniel E; Birkbak, Nicolai J; Behrens, Axel; Yousaf, Nadia; Popat, Sanjay; Hackshaw, Allan; Hiley, Crispin T; Litchfield, Kevin; McGranahan, Nicholas; Jamal-Hanjani, Mariam; Larkin, James; Lee, Se-Hoon; Turajlic, Samra; Swanton, Charles; Downward, Julian; Kassiotis, George

The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance

APOBEC3B在肺肿瘤演变和靶向癌症治疗耐药性中的作用

Deborah R Caswell #,Philippe Gui #,Manasi K Mayekar #,Emily K Law,Oriol Pich,Chris Bailey,Jesse Boumelha,D Lucas Kerr,Collin M Blakely,Tadashi Manabe,Carlos Martinez-Ruiz ,Bjorn Bakker,Juan De Dios Palomino Villcas,Natalie I Vokes ,Michelle Dietzen ,Mihaela Angelova,Beatrice Gini,Whitney Tamaki,Paul Allegakoen,Wei Wu,Timothy J Humpton ,William Hill,Mona Tomaschko,Wei-Ting Lu,Franziska Haderk,Maise Al Bakir,Ai Nagano,Francisco Gimeno-Valiente,Sophie de Carné Trécesson,Roberto Vendramin,Vittorio Barbè,Miriam Mugabo,Clare E Weeden,Andrew Rowan,Caroline E McCoach,Bruna Almeida ,Mary Green,Carlos Gomez,Shigeki Nanjo,Dora Barbosa,Chris Moore,Joanna Przewrocka,James R M Black ,Eva Grönroos,Alejandro Suarez-Bonnet ,Simon L Priestnall ,Caroline Zverev,Scott Lighterness,James Cormack,Victor Olivas,Lauren Cech,Trisha Andrews,Brandon Rule , Yuwei Jiao , Xinzhu Zhang , Paul Ashford , Cameron Durfee , Subramanian Venkatesan,Nuri Alpay Temiz  ,Lisa Tan,Lindsay K Larson,Prokopios P Argyris,William L Brown,Elizabeth A Yu  ,Julia K Rotow , Udayan Guha  ,Nitin Roper , Johnny Yu , Rachel I Vogel , Nicholas J Thomas,Antonio Marra , Pier Selenica , Helena Yu  ,Samuel F Bakhoum  ,Su Kit Chew,Jorge S Reis-Filho , Mariam Jamal-Hanjani,Karen H Vousden,Nicholas McGranahan ,Eliezer M Van Allen , Nnennaya Kanu,Reuben S Harris  ,Julian Downward,Trever G Bivona  ,Charles Swanton

Combining RAS(ON) G12C-selective inhibitor with SHP2 inhibition sensitises lung tumours to immune checkpoint blockade

将 RAS(ON) G12C 选择性抑制剂与 SHP2 抑制剂相结合可增强肺癌对免疫检查点阻断的敏感性

Panayiotis Anastasiou, Christopher Moore, Sareena Rana, Mona Tomaschko, Claire E Pillsbury, Andrea de Castro, Jesse Boumelha, Edurne Mugarza, Sophie de Carné Trécesson, Ania Mikolajczak, Cristina Blaj, Robert Goldstone, Jacqueline A M Smith, Elsa Quintana, Miriam Molina-Arcas, Julian Downward

Combining RAS(ON) G12C-selective inhibitor with SHP2 inhibition sensitises lung tumours to immune checkpoint blockade

RAS(ON) G12C选择性抑制剂与SHP2抑制剂联合使用可增强肺肿瘤对免疫检查点阻断疗法的敏感性。

Panayiotis Anastasiou,Christopher Moore,Sareena Rana,Mona Tomaschko,Claire E Pillsbury,Andrea de Castro,Jesse Boumelha,Edurne Mugarza,Sophie de Carné Trécesson,Ania Mikolajczak,Cristina Blaj,Robert Goldstone,Jacqueline A M Smith,Elsa Quintana,Miriam Molina-Arcas,Julian Downward

CRISPR-Cas9 Screening Identifies KRAS-Induced COX2 as a Driver of Immunotherapy Resistance in Lung Cancer

CRISPR-Cas9 筛查确定 KRAS 诱导的 COX2 是肺癌免疫疗法耐药性的驱动因素

Jesse Boumelha, Andrea de Castro, Nourdine Bah, Hongui Cha, Sophie de Carné Trécesson, Sareena Rana, Mona Tomaschko, Panayiotis Anastasiou, Edurne Mugarza, Christopher Moore, Robert Goldstone, Phil East, Kevin Litchfield, Se-Hoon Lee, Miriam Molina-Arcas, Julian Downward

CRISPR-Cas9 Screening Identifies KRAS-Induced COX2 as a Driver of Immunotherapy Resistance in Lung Cancer

CRISPR-Cas9筛选发现KRAS诱导的COX2是肺癌免疫治疗耐药性的驱动因素

Jesse Boumelha,Andrea de Castro,Nourdine Bah,Hongui Cha,Sophie de Carné Trécesson,Sareena Rana,Mona Tomaschko,Panayiotis Anastasiou,Edurne Mugarza,Christopher Moore,Robert Goldstone,Phil East,Kevin Litchfield,Se-Hoon Lee,Miriam Molina-Arcas,Julian Downward

Antibodies against endogenous retroviruses promote lung cancer immunotherapy

抗内源性逆转录病毒抗体促进肺癌免疫治疗

Kevin W Ng #, Jesse Boumelha #, Katey S S Enfield #, Jorge Almagro, Hongui Cha, Oriol Pich, Takahiro Karasaki, David A Moore, Roberto Salgado, Monica Sivakumar, George Young, Miriam Molina-Arcas, Sophie de Carné Trécesson, Panayiotis Anastasiou, Annika Fendler, Lewis Au, Scott T C Shepherd, Carlos M

An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy Combinations

KRAS 突变型肺癌的免疫原性模型可用于评估靶向治疗和免疫治疗组合

Jesse Boumelha #, Sophie de Carné Trécesson #, Emily K Law #, Pablo Romero-Clavijo, Matthew A Coelho, Kevin W Ng, Edurne Mugarza, Christopher Moore, Sareena Rana, Deborah R Caswell, Miguel Murillo, David C Hancock, Prokopios P Argyris, William L Brown, Cameron Durfee, Lindsay K Larson, Rachel I Voge

Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA

致癌性RAS信号通路通过稳定PD-L1 mRNA促进肿瘤免疫抵抗

Matthew A Coelho ,Sophie de Carné Trécesson ,Sareena Rana ,Davide Zecchin ,Christopher Moore ,Miriam Molina-Arcas ,Philip East ,Bradley Spencer-Dene ,Emma Nye ,Karin Barnouin ,Ambrosius P Snijders ,Wi S Lai ,Perry J Blackshear ,Julian Downward

Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA

致癌性RAS信号通路通过稳定PD-L1 mRNA促进肿瘤免疫抵抗

Matthew A Coelho,Sophie de Carné Trécesson,Sareena Rana,Davide Zecchin,Christopher Moore,Miriam Molina-Arcas,Philip East,Bradley Spencer-Dene,Emma Nye,Karin Barnouin,Ambrosius P Snijders,Wi S Lai,Perry J Blackshear,Julian Downward